Skip to main content
. 2020 Jul 9;14:1753466620938553. doi: 10.1177/1753466620938553

Figure 5.

Figure 5.

Comparison between the design of traditional clinical and innovative experiments for the evaluation of specific molecular targets in low incidence tumors.